Basel Medical Group Ltd Ordinary Shares (BMGL) - Total Liabilities
Based on the latest financial reports, Basel Medical Group Ltd Ordinary Shares (BMGL) has total liabilities worth $11.99 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BMGL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Basel Medical Group Ltd Ordinary Shares - Total Liabilities Trend (2022–2025)
This chart illustrates how Basel Medical Group Ltd Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Basel Medical Group Ltd Ordinary Shares generate to measure how efficiently the company converts operating cash flow to free cash.
Basel Medical Group Ltd Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Basel Medical Group Ltd Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Income Asset Management Group Ltd
AU:IAM
|
Australia | AU$7.68 Million |
|
Wise Group AB
ST:WISE
|
Sweden | Skr132.58 Million |
|
Daewoo SBI SPAC 1
KQ:215480
|
Korea | ₩8.09 Billion |
|
California Nanotechnologies Corp
V:CNO
|
Canada | CA$1.98 Million |
|
Value8 N.V
AS:PREVA
|
Netherlands | €20.41 Million |
|
Prairie Provident Resources Inc
TO:PPR
|
Canada | CA$174.93 Million |
|
Fingerprint Cards AB (publ)
ST:FING-B
|
Sweden | Skr32.20 Million |
|
Nur Ink Innovations Ltd
TA:NURI
|
Israel | ILA5.84 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Basel Medical Group Ltd Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Basel Medical Group Ltd Ordinary Shares worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Basel Medical Group Ltd Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below shows the annual total liabilities of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $11.99 Million | +37.08% |
| 2024-06-30 | $8.75 Million | -11.57% |
| 2023-06-30 | $9.89 Million | -24.74% |
| 2022-06-30 | $13.14 Million | -- |
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more